What is Genequest Diagnostics?
GeneQuest Diagnostics is a specialized provider of forensic genomics services, offering professional consultation and detailed analysis for both criminal and civil legal cases. Their comprehensive service portfolio encompasses advanced techniques such as nuclear short tandem repeats (STR), mitochondrial DNA (mtDNA), single nucleotide polymorphism (SNP), and NextGen sequencing. The company supports the legal community across the United States, Canada, and Europe by providing thorough casefile reviews, independent laboratory re-analysis, and expert preparation for trial testimony. GeneQuest Diagnostics is dedicated to delivering precise and actionable data, reinforcing its commitment to high-quality forensic analysis and robust educational support for its clientele.
How much funding has Genequest Diagnostics raised?
Genequest Diagnostics has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
What's next for Genequest Diagnostics?
With the recent substantial expansion capital, Genequest Diagnostics is poised for significant scaling and enhancement of its forensic genomics capabilities. This strategic investment, characteristic of a company at the Series B/C stage, will likely fuel advancements in their analytical technologies, broaden their service reach into new jurisdictions, and potentially expand their team of scientific and legal experts. The focus on expansion capital suggests a strategic push to solidify their market leadership and capitalize on the growing demand for sophisticated DNA analysis in legal proceedings.
See full Genequest Diagnostics company page
